The relationship between applied energy and ablation zone volume in patients with hepatocellular carcinoma and colorectal liver metastasis

被引:37
作者
Heerink, Wouter J. [1 ,2 ]
Solouki, A. Millad [1 ]
Vliegenthart, Rozemarijn [1 ,2 ]
Ruiter, Simeon J. S. [3 ]
Sieders, Egbert [3 ]
Oudkerk, Matthijs [2 ]
de Jong, Koert P. [2 ,3 ]
机构
[1] Univ Groningen, Univ Med Ctr Groningen, Dept Radiol, Hanzeplein 1, NL-9713 GZ Groningen, Netherlands
[2] Univ Groningen, Univ Med Ctr Groningen, Ctr Med Imaging North East Netherlands, Groningen, Netherlands
[3] Univ Groningen, Univ Med Ctr Groningen, Dept HPB Surg, Groningen, Netherlands
关键词
Ablation techniques; Carcinoma; Hepatocellular; Radiology; Interventional; Multidetector computed tomography; Liver diseases; MICROWAVE THERMOSPHERE ABLATION; RADIOFREQUENCY ABLATION; RISK-FACTORS; PROGNOSTIC-FACTORS; TUMORS; RECURRENCE; SEVERITY; DISEASE;
D O I
10.1007/s00330-017-5266-1
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
To study the ratio of ablation zone volume to applied energy in computed tomography (CT)-guided radiofrequency ablation (RFA) and microwave ablation (MWA) in patients with hepatocellular carcinoma (HCC) in a cirrhotic liver and in patients with colorectal liver metastasis (CRLM). In total, 90 liver tumors, 45 HCCs in a cirrhotic liver and 45 CRLMs were treated with RFA or with one of two MWA devices (MWA_A and MWA_B), resulting in 15 procedures for each tumor type, per device. Device settings were recorded and the applied energy was calculated. Ablation volumes were segmented on the contrast-enhanced CT scans obtained 1 week after the procedure. The ratio of ablation zone volume in milliliters to applied energy in kilojoules was determined for each procedure and compared between HCC (R (HCC)) and CRLM (R (CRLM)), stratified according to ablation device. With RFA, R (HCC) and R (CRLM) were 0.22 mL/kJ (0.14-0.45 mL/kJ) and 0.15 mL/kJ (0.14-0.22 mL/kJ; p = 0.110), respectively. With MWA_A, R (HCC) was 0.81 (0.61-1.07 mL/kJ) and R (CRLM) was 0.43 (0.35-0.61 mL/kJ; p = 0.001). With MWA_B, R (HCC) was 0.67 (0.41-0.85 mL/kJ) and R (CRLM) was 0.43 (0.35-0.61 mL/kJ; p = 0.040). With RFA, there was no significant difference in energy deposition ratio between tumor types. With both MWA devices, the ratios were higher for HCCs. Tailoring microwave ablation device protocols to tumor type might prevent incomplete ablations. aEuro cent HCCs and CRLMs respond differently to microwave ablation aEuro cent For MWA, CRLMs required more energy to achieve a similar ablation volume aEuro cent Tailoring ablation protocols to tumor type might prevent incomplete ablations.
引用
收藏
页码:3228 / 3236
页数:9
相关论文
共 20 条
[1]  
Ahmed M, 2014, RADIOLOGY, V273, P241, DOI [10.1148/radiol.14132958, 10.1016/j.jvir.2014.08.027]
[2]   Microwave ablation of primary and secondary liver tumours: ex vivo, in vivo, and clinical characterisation [J].
Amabile, Claudio ;
Ahmed, Muneeb ;
Solbiati, Luigi ;
Meloni, Maria Franca ;
Solbiati, Marco ;
Cassarino, Simone ;
Tosoratti, Nevio ;
Nissenbaum, Yitzhak ;
Ierace, Tiziana ;
Goldberg, S. Nahum .
INTERNATIONAL JOURNAL OF HYPERTHERMIA, 2017, 33 (01) :34-42
[3]   Laparoscopic microwave thermosphere ablation of malignant liver tumors: an initial clinical evaluation [J].
Berber, Eren .
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 2016, 30 (02) :692-698
[4]   Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies - Results in 123 patients [J].
Curley, SA ;
Izzo, F ;
Delrio, P ;
Ellis, LM ;
Granchi, J ;
Vallone, P ;
Fiore, F ;
Pignata, S ;
Daniele, B ;
Cremona, F .
ANNALS OF SURGERY, 1999, 230 (01) :1-8
[5]   Physical modeling of microwave ablation zone clinical margin variance [J].
Deshazer, Garron ;
Merck, Derek ;
Hagmann, Mark ;
Dupuy, Damian E. ;
Prakash, Punit .
MEDICAL PHYSICS, 2016, 43 (04) :1764-1776
[6]  
Hashimoto K, 2006, ONCOL REP, V16, P677
[7]   Outcomes after resection and/or radiofrequency ablation for recurrence after treatment of colorectal liver metastases [J].
Hof, J. ;
Wertenbroek, M. W. J. L. A. E. ;
Peeters, P. M. J. G. ;
Widder, J. ;
Sieders, E. ;
de Jong, K. P. .
BRITISH JOURNAL OF SURGERY, 2016, 103 (08) :1055-1062
[8]   Risk factors for long-term prognosis in hepatocellular carcinoma after radiofrequency ablation therapy: the clinical implication of aspartate aminotransferase-platelet ratio index [J].
Kao, Wei-Yu ;
Chiou, Yi-You ;
Hung, Hung-Hsu ;
Chou, Yi-Hong ;
Su, Chien-Wei ;
Wu, Jaw-Ching ;
Huo, Teh-Ia ;
Huang, Yi-Hsiang ;
Lin, Han-Chieh ;
Lee, Shou-Dong .
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2011, 23 (06) :528-536
[9]   Intrahepatic recurrence after percutaneous radiofrequency ablation of hepatocellular carcinoma: Analysis of the pattern and risk factors [J].
Kim, Young-sun ;
Rhim, Hyunchul ;
Cho, On Koo ;
Koh, Byung Hee ;
Kim, Yongsoo .
EUROPEAN JOURNAL OF RADIOLOGY, 2006, 59 (03) :432-441
[10]   Risk factors and prognostic factors of local recurrence after radiofrequency ablation of hepatocellular carcinoma [J].
Lam, Vincent Wai-To ;
Ng, Kelvin Kwok-Chai ;
Chok, Kenneth Siu-Ho ;
Cheung, Tan-To ;
Yuen, Jimmy ;
Tung, Helen ;
Tso, Wai-Kuen ;
Fan, Sheung-Tat ;
Poon, Ronnie T. P. .
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2008, 207 (01) :20-29